Cihan Ay and Colleagues on Thromboembolism and Bleeding in Multiple Myeloma
RPTH Journal shared on LinkedIn:
”In newly diagnosed multiple myeloma patients on immunomodulatory drugs, VTE and bleeding risks remain high.
Direct oral anticoagulants showed a trend toward lower VTE vs aspirin/no prophylaxis, but bleeding rates were similar across all strategies.
Check out the full article for more details.”
Read the full article in RPTH.
Article: Thromboembolism and bleeding in newly diagnosed multiple myeloma: rates, risk profile, and patterns of thromboprophylaxis
Authors: Lea Vospernik, Hermine Agis, Cihan Ay, Lina Rüsing, Heinz Gisslinger, Christina Brunbauer, Clara Sophie Michel, Ingrid Simonitsch-Klupp, Alexandra Kaider, Maria-Theresa Krauth, Julia Riedl
Stay updated on all scientific advances in the field of clotting disorders with Hemostasis Today.
-
Oct 3, 2026, 17:26Karel Kostev։ When First Anticoagulant Prescriptions Are Not Dispensed
-
Oct 3, 2026, 17:11Nabila Hasan: Thalassemia Awareness And Prevention
-
Oct 3, 2026, 17:03Pasinee Sangsiwarit: Neutrophil Dysfunction In β-Thalassemia
-
Oct 3, 2026, 16:18Mira Kassouf: Reactivating An Embryonic Gene To Treat α-Thalassemia
-
Oct 3, 2026, 15:49Behnood Bikdeli: COATED_AIR Trial Design Published as Enrollment Reaches 3,000 Patients
-
Oct 3, 2026, 15:25Vanrose Panashe Nyamangodo: A Multi-Task Deep Learning Model For Malaria And Anemia
-
Oct 3, 2026, 14:52Benny Sorensen: Glanzmann’s Thrombasthenia Finally Assigned Dedicated ICD-10 Code
-
Oct 3, 2026, 14:52The Real-World Burden Of DVT In Traumatic Fractures – ISTH
-
Oct 3, 2026, 14:41How Much Do We Really Know About The Global Burden Of Venous Thromboembolism? – World Thrombosis Day